Strome Mark E's Form 4 filing
Zivo Bioscience, Inc. (ZIVO) · filed Oct 20, 2025
- Accession no.
- 0001213900-25-100376
- Filed
- Oct 20, 2025, 4:19 PM ET
- Trade date
- Oct 13, 2025
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $250.0K. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Strome Mark ECIK 0000919484 | 10% Owner |
| Strome Investment Management LPCIK 0000936711 | Other: Affiliate of 10% Owner |
| Strome Group, Inc.CIK 0001724136 | Other: Affiliate of 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 13, 2025 | Common Stock | PPurchaseAcquired | +20,259 | $12.34 | +$249,996.06 | 452,942 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 13, 2025 | Common Stock | PPurchaseAcquired | +2,025 | $0.00 | $0 | 43,071 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.